Emily Banda [not real name] is about 55. A
grandmother of six, she had three children who are now dead, leaving her with
the burden of looking after the grandchildren.
Her skin is close to her
bones and her eyes beam from deep inside her skull. It is a familiar
story—Banda is HIV positive.
Gogo Banda flanked by her two friends - Whats their future? |
“I loved my deceased daughter so
much that I cared less about her ailment and in the process of taking care of
her during her sickness, I contracted the virus,” said Banda.
She discovered her condition
after illness would not leave her a few months after burying her daughter. She
is now three months on anti-retro-viral therapy (ART). She is not fully used to
the drugs and she is feeling the effects of the powerful medicines.
Banda sits in a hut in Lilongwe’s
Area 21 flanked by three other women who also carry the HIV virus. The reason
their faces brighten up is that the life-prolonging medicines give them hope
that they will see another day at least.
That could all change after 2014.
A crucial donor who buys most of
the anti-retroviral drugs (ARVs) for Malawi will no longer do so after 2014 and
unless Malawi identifies another donor or buys the ARVs herself, HIV and Aids
will ravage people such as Banda and take an enormous toll on the impoverished
nation.
The revelation has been discussed
in a resource mapping document prepared by the Ministry of Health and Clinton
Health Access Initiative titled HIV
Funding in Malawi: Key Findings from Resource Mapping, published on
18 September this year.
“55 percent of HIV funding in
Malawi is at risk with the Global Fund grant ending in 2014,” warns the
document.
The report says although the
current grant will end in 2014, Malawi will have access to two years of funding
that will maintain drug purchases for all existing patients which will allow
for continued treatment, but with limited chances of being increased.
Banda and the other women that I assembled
in Area 21 are worried by the spectre of a potential scaledown in the
distribution of ARVs.
“ARVs gave us hope; we are now
able to do manual labour to take care of our families because ARVs give us
strength. Cessation of HIV funding would be killing the Malawi nation because
we are not alone, there are many of us,” said one woman who does laundry in
people’s houses for a living.
Another woman pointed to her
pregnancy, saying despite having HIV, she can afford to bear a child because of
the drugs.
“Recall the deaths that used to
be there in the late 90s. ARVs give us a reprieve. If they stop giving people
ARVs, the number of orphans will rise sharply. Imagine, we are already
unhealthy with ARVs; how will life be without them?” she said.
The woman added that without
drugs, stigma will come back as it will be easy to identify those with HIV.
Martha Kwataine, executive
director of the Malawi Health Equity Network, says it is time Malawi put ARV
purchases in the budget.
Kwataine - lets act with speed |
“It’s high time Malawi began to
show its commitment to allocating resources for ART,” said Kwataine.
Board chairperson of the National
Aids Commission (NAC) Mara Kumbweza-Banda played down the gravity of the
situation, saying Global Fund is not the only partner supporting Malawi in HIV
interventions.
“Even if Global Fund withdrew
today, we will be able to manage. We have other strong partners such as the
United States Government, CDC and others,” said Kumbweza-Banda.
Kumbweza-Banda - Not worried |
She said independence cannot come
overnight, arguing that Malawi is making strides in the fight against HIV and
Aids.
Out of the $354 million (about
K114 billion) that was channelled to fight all diseases in the 2012/13
financial year, 60 percent went to HIV. That is a staggering $212 million
(about K70 billion).
The $212 million, which comprises
money from the Global Fund, Health Resources and Services Administration, and
UNAIDS, among others, will shrink to $117 million next year, $84 million in
2014-15 and remain the same $84 million in 2015-16 following the decreases in
funding from Global Fund and others.
According to CHAI (clintonfund.org), the
average cost of treating an HIV patient for one year in Malawi is $200 (K64
000).
No comments:
Post a Comment